Is CGON or DOCS more profitable?

DOCS runs the higher net margin — CGON at -3602.68% versus DOCS at 25.48%.

CG Oncology Inc. (CGON) vs Doximity, Inc. (DOCS)

A side-by-side comparison of CG Oncology Inc. and Doximity, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CGON

CG Oncology Inc.

$6.06B

$68.71HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

DOCS

Doximity, Inc.

$5.35B

$28.58HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CGON vs DOCS

growth of $100 · dividends reinvested · last 3y

CGON +84.9% (+22.7%/yr)DOCS -4.0% (-1.3%/yr)CGON compounded faster over this window

CGON DOCS

CGON vs DOCS: by the numbers

•CGON is the larger company ($6.06B vs $5.35B market cap).
•DOCS is profitable (25.48% net margin) while CGON runs a net loss (-3602.68%).

Metrics side by side

Valuation

Metric	CGON	DOCS
P/E ratio	N/A	33.62
Forward P/E	N/A	21.21
PEG ratio	N/A	0.64
P/S ratio	973.09	8.15
P/B ratio	5.89	5.83
EV / EBITDA	N/A	24.01
FCF yield	N/A	5.60%

Profitability

Metric	CGON	DOCS
Gross margin	-15.02%	88.07%
Operating margin	-4722.13%	29.60%
Net margin	-3602.68%	25.48%
ROE	-21.80%	18.24%
ROIC	-24.33%	15.35%

Growth (annualized)

Metric	CGON	DOCS
Revenue CAGR (5Y)	N/A	21.94%
EPS CAGR (5Y)	N/A	54.32%
FCF CAGR (5Y)	N/A	23.75%
Total return CAGR (5Y)	N/A	-18.23%

Frequently asked

Is CGON or DOCS more profitable?: DOCS runs the higher net margin — CGON at -3602.68% versus DOCS at 25.48%.

Go deeper

Full CGON analysis Full DOCS analysis Interactive comparison tool

Dig into the metrics

Doximity P/E ratio CG Oncology ROE Doximity ROE CG Oncology operating margin Doximity operating margin CG Oncology revenue growth Doximity revenue growth CG Oncology free cash flow Doximity free cash flow

CG Oncology & Doximity appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.